[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"glenohumeral-subluxation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:glenohumeral-subluxation":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100625501","electrotherapeutic-interventions-for-glenohumeral-subluxation-after-stroke-100625501",false,"NCT07423455","Electrotherapeutic Interventions for Glenohumeral Subluxation After Stroke","Comparison of the Clinical and Sonographic Outcomes of NMES and EMG Biofeedback Therapies in Stroke Patients With Glenohumeral Subluxation: Randomized Clinical Trial","Inclusion Criteria:\n\n* ≥18 years of age,\n* Disease duration \\>3 months,\n* Glenohumeral subluxation (GHS) confirmed by ultrasonography (USG),\n* Upper extremity and hand Brunnstrom motor stages between 2 and 5\n\nExclusion Criteria:\n\n* Mini-Mental State Examination (MMSE) score \\\u003C24,\n* Visual\u002Fhearing impairments, or neglect,\n* Steroid injection for shoulder pain within the last 3 months,\n* Unstable systemic disease,\n* Spasticity with Modified Ashworth Scale (MAS) score 3-4,\n* Presence of metal implants or pacemaker","ALL","18 Years",{"count":19,"type":20},36,"ESTIMATED","INTERVENTIONAL",[23],"NA","The aim of this single-blind randomized controlled trial is to compare the effects of two therapies-neuromuscular electrical stimulation (NMES) and electromyographic (EMG) biofeedback-in stroke patients with shoulder (glenohumeral) subluxation.\n\nThe study will evaluate changes in shoulder structure and function by measuring the acromion-greater tuberosity distance, supraspinatus and posterior deltoid muscle thickness, shoulder range of motion, and Brunnstrom stage of the upper extremity and hand. Clinical outcomes such as shoulder pain, stroke-specific quality of life, and the Shoulder Pain and Disability Index (SPADI) will also be assessed.\n\nThis trial is designed to provide evidence on which therapy may be more effective for improving shoulder stability, reducing pain, and enhancing quality of life in stroke survivors with shoulder subluxation.",[26,27],"Glenohumeral Subluxation","Stroke",[29,30,31,32,33],"stroke","glenohumeral subluxation","Electrotherapeutic Interventions","NMES","EMG Biofeedback","NOT_YET_RECRUITING","2026-02-19",{"date":37,"type":38},"2026-02-20","ACTUAL",{"date":40,"type":20},"2026-02-27",{"date":42,"type":20},"2026-12-27",{"name":44,"class":45},"Şahide Eda ARTUÇ","OTHER"]